Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Net Cash Flow (2023 - 2025)

Rallybio (RLYB) has disclosed Net Cash Flow for 3 consecutive years, with -$748000.0 as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 93.45% to -$748000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.5 million through Dec 2025, up 264.96% year-over-year, with the annual reading at $17.5 million for FY2025, 264.96% up from the prior year.
  • Net Cash Flow hit -$748000.0 in Q4 2025 for Rallybio, down from $22.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $22.7 million in Q3 2025 to a low of -$17.4 million in Q1 2023.
  • Historically, Net Cash Flow has averaged -$2.1 million across 3 years, with a median of -$3.9 million in 2024.
  • Biggest YoY gain for Net Cash Flow was 164.54% in 2024; the steepest drop was 313.96% in 2024.
  • Year by year, Net Cash Flow stood at $5.3 million in 2023, then tumbled by 313.96% to -$11.4 million in 2024, then skyrocketed by 93.45% to -$748000.0 in 2025.
  • Business Quant data shows Net Cash Flow for RLYB at -$748000.0 in Q4 2025, $22.7 million in Q3 2025, and -$5.3 million in Q2 2025.